======= ADCY5 ======= == Gene Information == * **Official Symbol**: ADCY5 * **Official Name**: adenylate cyclase 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=111|111]] * **UniProt**: [[https://www.uniprot.org/uniprot/O95622|O95622]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ADCY5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ADCY5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600293|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the membrane-bound adenylyl cyclase enzymes. Adenylyl cyclases mediate G protein-coupled receptor signaling through the synthesis of the second messenger cAMP. Activity of the encoded protein is stimulated by the Gs alpha subunit of G protein-coupled receptors and is inhibited by protein kinase A, calcium and Gi alpha subunits. Single nucleotide polymorphisms in this gene may be associated with low birth weight and type 2 diabetes. Alternatively spliced transcript variants that encode different isoforms have been observed for this gene. [provided by RefSeq, Dec 2010]. * **UniProt Summary**: Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling (PubMed:15385642, PubMed:26206488, PubMed:24700542). Mediates signaling downstream of ADRB1 (PubMed:24700542). Regulates the increase of free cytosolic Ca(2+) in response to increased blood glucose levels and contributes to the regulation of Ca(2+)-dependent insulin secretion (PubMed:24740569). {ECO:0000269|PubMed:15385642, ECO:0000269|PubMed:24700542, ECO:0000269|PubMed:24740569, ECO:0000269|PubMed:26206488}. |DUF1053| |Guanylate cyc| |adenosine receptor signaling pathway| |adenylate cyclase-inhibiting dopamine receptor signaling pathway| |cAMP biosynthetic process| |adenylate cyclase activity| |adenylate cyclase-activating dopamine receptor signaling pathway| |response to forskolin| |cellular response to forskolin| |adenylate cyclase binding| |response to platelet aggregation inhibitor| |activation of protein kinase A activity| |G protein-coupled purinergic receptor signaling pathway| |cAMP metabolic process| |cyclic nucleotide biosynthetic process| |cyclic purine nucleotide metabolic process| |cellular response to glucagon stimulus| |purinergic receptor signaling pathway| |dopamine receptor signaling pathway| |renal water homeostasis| |response to glucagon| |activation of adenylate cyclase activity| |cyclic nucleotide metabolic process| |intermediate filament cytoskeleton| |neuromuscular process controlling balance| |regulation of insulin secretion involved in cellular response to glucose stimulus| |scaffold protein binding| |multicellular organismal water homeostasis| |water homeostasis| |adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway| |cellular response to alcohol| |cellular response to dopamine| |response to dopamine| |cellular response to ketone| |signal transduction involved in cellular response to ammonium ion| |cellular response to catecholamine stimulus| |cellular response to monoamine stimulus| |response to catecholamine| |response to monoamine| |neuromuscular process| |renal system process| |cellular response to antibiotic| |adenylate cyclase-activating G protein-coupled receptor signaling pathway| |cellular response to ammonium ion| |cAMP-mediated signaling| |purine ribonucleotide biosynthetic process| |purine nucleotide biosynthetic process| |ribonucleotide biosynthetic process| |ribose phosphate biosynthetic process| |purine-containing compound biosynthetic process| |cyclic-nucleotide-mediated signaling| |regulation of insulin secretion| |response to ammonium ion| |response to ketone| |locomotory behavior| |cilium| |adenylate cyclase-modulating G protein-coupled receptor signaling pathway| |regulation of peptide hormone secretion| |response to alcohol| |nucleotide biosynthetic process| |G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger| |nucleoside phosphate biosynthetic process| |cellular response to peptide hormone stimulus| |regulation of hormone secretion| |positive regulation of cytosolic calcium ion concentration| |response to antibiotic| |purine ribonucleotide metabolic process| |multicellular organismal homeostasis| |cellular response to peptide| |ribonucleotide metabolic process| |regulation of cytosolic calcium ion concentration| |activation of protein kinase activity| |purine nucleotide metabolic process| |ribose phosphate metabolic process| |second-messenger-mediated signaling| |purine-containing compound metabolic process| |response to peptide hormone| |cellular response to drug| |cellular calcium ion homeostasis| |nucleotide metabolic process| |calcium ion homeostasis| |nucleoside phosphate metabolic process| |regulation of protein secretion| |cellular divalent inorganic cation homeostasis| |response to peptide| |protein heterodimerization activity| |divalent inorganic cation homeostasis| |regulation of peptide secretion| |regulation of body fluid levels| |cellular response to lipid| |positive regulation of protein kinase activity| |regulation of hormone levels| |organophosphate biosynthetic process| |nucleobase-containing small molecule metabolic process| |cellular response to organic cyclic compound| |cellular metal ion homeostasis| |behavior| |positive regulation of kinase activity| |cellular response to organonitrogen compound| |cellular response to hormone stimulus| |carbohydrate derivative biosynthetic process| |metal ion homeostasis| |cellular cation homeostasis| |cellular ion homeostasis| |positive regulation of transferase activity| |cellular response to nitrogen compound| |cation homeostasis| |regulation of protein transport| |inorganic ion homeostasis| |regulation of peptide transport| |cellular chemical homeostasis| |regulation of establishment of protein localization| |regulation of secretion by cell| |ion homeostasis| |regulation of protein kinase activity| |regulation of secretion| |response to lipid| |regulation of kinase activity| |organophosphate metabolic process| |cellular homeostasis| |response to hormone| |regulation of cellular localization| |response to organic cyclic compound| |regulation of transferase activity| |response to organonitrogen compound| |positive regulation of protein phosphorylation| |response to drug| |carbohydrate derivative metabolic process| |regulation of protein localization| |cellular response to oxygen-containing compound| |positive regulation of phosphorylation| |response to nitrogen compound| |nucleobase-containing compound biosynthetic process| |chemical homeostasis| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |cellular response to endogenous stimulus| |positive regulation of protein modification process| |organic cyclic compound biosynthetic process| |G protein-coupled receptor signaling pathway| |nervous system process| |integral component of plasma membrane| |organonitrogen compound biosynthetic process| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |response to endogenous stimulus| |ATP binding| |response to oxygen-containing compound| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |cellular nitrogen compound biosynthetic process| |homeostatic process| |intracellular signal transduction| |positive regulation of protein metabolic process| |small molecule metabolic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of protein modification process| |regulation of transport| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|-1.72| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7061 * **Expression level (log2 read counts)**: 2.61 {{:chemogenomics:nalm6 dist.png?nolink |}}